Skip to main content
. 2020 May 14;8(7):2310–2321.e4. doi: 10.1016/j.jaip.2020.05.007

Figure E2.

Figure E2

Sensitivity analysis of incremental risk of COVID-19 from visiting allergy clinic for immunotherapy. Dotted line represents the threshold at which the net monetary benefit of HITSA exceed clinic AIT. Note: Axes do not start at 0.